Table 5.
Covariate* | Estimate** (95% CI) | p-value |
---|---|---|
Age at PaC Diagnosis | 0.001 | |
Ordinal Effect | 0.02 (0.01, 0.02) | |
Usual Adult BMI | 0.004 | |
Ordinal Effect | 0.04 (0.01, 0.06) | |
Site of Pancreatic Mass | <.001 | |
Head/Head and Body | 0.00 (ref) | |
Body/Tail | 1.13 (0.75, 1.50) | |
NOS | −0.22 (−0.92, 0.49) | |
Stage at Diagnosis | 0.026 | |
I | 0.00 (ref) | |
II | 0.56 (0.13, 1.00) | |
III | 0.00 (−1.10, 1.10) | |
Tumor grade | 0.008 | |
Moderately/Well differentiated | 0.00 (ref) | |
Poorly differentiated | 0.25 (−0.13, 0.63) | |
Undifferentiated | 0.86 (0.31, 1.41) | |
Duration of Diabetes | <.001 | |
Non-DM | 0.00 (ref) | |
Long-standing | −0.50 (−1.03, 0.04) | |
New-onset | 0.41 (0.09, 0.73) |
Also included gender, number of positive lymph nodes, angiolymphatic invasion, family history of diabetes and perinuerual invasion. Only significant covariates are shown.
The estimate reflects the increase in tumor size (cm) associated with each covariate.